Gastroesophageal Reflux Disease and Connective Tissue Disorders: Pathophysiology and Implications for Treatment
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
It has been postulated that in patients with connective tissue disorders (CTD) and gastroesophageal reflux disease (GERD), esophageal function is generally deteriorated, often with complete absence of peristalsis. This belief has led to the common recommendation of avoiding antireflux surgery for fear of creating or worsening dysphagia.
We hypothesized that in most patients with CTD and GERD: (a) esophageal function is often preserved; (b) peristalsis is more frequently absent when end-stage lung disease (ESLD) is also present; (c) a tailored surgical approach (partial or total fundoplication) based on the findings of esophageal manometry allows control of reflux symptoms without a high incidence of postoperative dysphagia. Forty-eight patients with CTD were evaluated by esophageal manometry and 24-hour pH monitoring (EFT). Twenty patients (group A) had EFT because of foregut symptoms, and 28 patients with ESLD (group B) had EFT as part of the lung transplant evaluation. Two hundred and eighty-six consecutive patients with GERD by pH monitoring served as a control group (group C). A laparoscopic fundoplication was performed in two group A patients (total), eight group B patients (three patients total, five patients partial) and in all group C patients (total).
Esophageal peristalsis was preserved in all patients with CTD and GERD. In contrast, peristalsis was absent in about half of patients when ESLD was also present. A tailored surgical approach resulted in control of reflux symptoms in all patients. One patient only developed postoperative dysphagia, which resolved with two Savary dilatations.
These data show that esophageal motor function is preserved in most patients with CTD, so that they should be offered antireflux surgery early in the course of their disease to prevent esophageal and respiratory complications. In patients with ESLD in whom peristalsis is absent, a partial rather than a total fundoplication should be performed, as it allows control of reflux symptoms while avoiding postoperative dysphagia.
- Zamost BJ, Hirschberg J, Ippoliti AF, Furst DE, Clements PJ, Weinstein WM. Esophagitis in scleroderma. Prevalence and risk factors. Gastroenterology 1987;92:421–428.
- Remy-Jardin M, Remy J, Wallaert B, Bataille D, Hatron PY. Pulmonary involvement in progressive systemic sclerosis: sequential evaluation with CT, pulmonary function tests, and bronchoalveolar lavage. Radiology 1993;188:499–506.
- Shoenut JP, Wieler JA, Micflikier AB. The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole. Aliment Pharmacol Ther 1993;7:509–13. CrossRef
- Tedesco P, Lobo E, Fisichella PM, Way LW, Patti MG. Laparoscopic fundoplication in elderly patients with gastroesophageal reflux disease. Arch Surg 2006;141:289–292. doi:10.1001/archsurg.141.3.289. CrossRef
- Sweet MP, Herbella FA, Leard L et al. The prevalence of distal and proximal gastroesophageal reflux in patients awaiting lung transplantation. Ann Surg 2006;244:491–497.
- Patti MG, Fisichella PM, Perretta S. Preoperative evaluation of patients with gastroesophageal reflux disease. J Laparoendosc Adv Surg Tech A 2001;11:327–331. doi:10.1089/10926420152761833. CrossRef
- Jamieson JR, Stein HJ, DeMeester TR et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol 1992;87:1102–1111.
- Patti MG, Robinson T, Galvani C, Gorodner MV, Fisichella PM, Way LW. Total fundoplication is superior to partial fundoplication even when esophageal peristalsis is weak. J Am Coll Surg 2004;198:863–870. doi:10.1016/j.jamcollsurg.2004.01.029. CrossRef
- Henry MACA, Harbermann MC, Rocha OM. Esophageal motor disturbances in progressive systemic sclerosis. Dis Esophagus 1999;12:51–53. doi:10.1046/j.1442-2050.1999.00005.x. CrossRef
- Airo' P, Della Casa D, Danieli E, Missale G, Cattaneo R, Cestari R. Oesophageal manometry in early and definite systemic sclerosis. Clin Rheumatol 2005;24:370–376. doi:10.1007/s10067-004-1049-6. CrossRef
- Marie I, Dominique S, Levesque H, Ducrotte P, Denis P, Hellot MF et al. Esophageal involvement and pulmonary manifestations in systemic sclerosis. Arthritis Rheum 2001;45:346–354. doi:10.1002/1529-0131(200108)45:4<346::AID-ART347>3.0.CO;2-L. CrossRef
- Johnson DA, Drane WE, Curran J, Cattau EL, Ciarleglio C, Khan A et al. Pulmonary disease in progressive systemic sclerosis. A complication of gastroesophageal reflux and occult aspiration? Arch Intern Med 1989;149:589–593. doi:10.1001/archinte.149.3.589. CrossRef
- Patti MG, debas HT, Pellegrini CA. Clinical and functional characterization of high gastroesophageal reflux. Am J Surg 1993;165:163–166. doi:10.1016/S0002-9610(05)80421-0. CrossRef
- Diener U, Patti MG, Molena D, Fsichella PM, Way LW. Esophageal dysmotility and gastroesophageal reflux disease. J Gastrointest Surg 2001;5:260–265. doi:10.1016/S1091-255X(01)80046-9. CrossRef
- Kahrilas PJ, Dodds WJ, Hogan WJ. Effect of peristaltic dysfunction on esophageal volume clearance. Gastroenterol 1988;94:73–80.
- Afeltra A, Zennaro D, Garzia P, Gigante A, Vadacca M, Riggiero A et al. Prevalence of interstitial lung involvement in patients with connective tissue diseases assessed with high-resolution computed tomography. Scand J Rheumatol. 2006;35:388–394. doi:10.1080/03009740600844381. CrossRef
- Bryan C, Knight C, Black CM, Silman AJ. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999;42:2660–2665. doi:10.1002/1529-0131(199912)42:12<2660::AID-ANR23>3.0.CO;2-N. CrossRef
- Hendel L, Hage E, Hendel J, Stentoft P. Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis. Aliment Pharmacol Ther 1992;6:565–577.
- Janiak P, Thumshirn M, Menne D, Fox M, Halim S, Fried M et al. Clinical trial: the effect of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis—a randomized controlled, cross-over trial. Aliment Pharmacol Ther 2007;26:1259–1265.
- Tamhankar AP, Peters JH, Portale G, Hsieh CC, Hagen JA, Bremner CG et al. Omeprazole does not reduce gastroesophageal relux: new insights using multichannel intraluminal impedance technology. J Gastrointest Surg 2004;8:888–896. doi:10.1016/j.gassur.2004.08.001. CrossRef
- Mianie I, Tutuian R, Shay S, Vela M, Zhang X, Sifrim D et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicentre study using combined ambulatory impedance-pH monitoring. Gut 2006;55:1398–1402. doi:10.1136/gut.2005.087668. CrossRef
- Mainie I, Tutuina R, Agrawal A, Admas D, Castell D. Comibined multichannel intraluminal impedance-pH monitoring to select patients with persistent gastro-esophageal reflux for laparoscopic Nissen fundoplication. Br J Surg 2006;93:1483–1487. doi:10.1002/bjs.5493. CrossRef
- Richards WO, Torquati A, Holzman MD, Khaitan L, Byrne D, Lufti R et al. Heller myotomy versus Heller myotomy with Dor fundoplication for achalasia: a prospective, randomized, double blind clinical trial. Ann Surg 2004;240:691–694. doi:10.1097/01.sla.0000136940.32255.51. CrossRef
- Watson DI, Jamieson GG, Bessell JR, Devitt PG. Laparoscopic fundoplication in patients with an aperistaltic esophagus and gastroesophageal reflux. Dis Esophagus 2006;19:94–98. doi:10.1111/j.1442-2050.2006.00547.x. CrossRef
- Dantas RO, Meneghelli UG, Oliveira RB, Villanova MG. Esophageal dysfunction does not always worsen in systemic sclerosis. J Clin Gastroenterol 1993;17:281–285. doi:10.1097/00004836-199312000-00003. CrossRef
- Heider TR, Behrns KE, Koruda MF, Shaheen NF, Lucktong TA, Bradshaw B et al. Fundoplication improves disordered esophageal motility. J Gastrointest Surg 2003;7:159–163. doi:10.1016/S1091-255X(02)00145-2. CrossRef
- Herbella FAM, Tedesco P, Nipomnick I, Fisichella PM, Patti MG. Effect of partial and total fundoplication on esophageal body motility. Surg Endosc 2007;21:285–288. doi:10.1007/s00464-006-0108-2. CrossRef
- Gastroesophageal Reflux Disease and Connective Tissue Disorders: Pathophysiology and Implications for Treatment
Journal of Gastrointestinal Surgery
Volume 12, Issue 11 , pp 1900-1906
- Cover Date
- Print ISSN
- Online ISSN
- Additional Links
- Connective tissue disorders
- Gastroesophageal reflux disease
- Esophageal peristalsis
- Esophageal manometry
- Ambulatory pH monitoring
- Laparoscopic fundoplication
- End-stage lung disease
- Industry Sectors
- Author Affiliations
- 1. Department of Surgery, University of Chicago Pritzker School of Medicine, 5841 S. Maryland Ave, MC 5095, Room G-201, Chicago, IL, 60637, USA
- 2. Department of Surgery, University of California, San Francisco, San Francisco, CA, USA
- 3. Department of Surgery, Loyola University Medical Center, Maywood, IL, USA